Phibro Animal Health/$PAHC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Phibro Animal Health
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Ticker
$PAHC
Sector
Primary listing
Industry
Pharmaceuticals
Headquarters
Employees
1,940
Website
PAHC Metrics
BasicAdvanced
$1.2B
37.39
$0.78
0.62
$0.48
1.64%
Price and volume
Market cap
$1.2B
Beta
0.62
52-week high
$31.80
52-week low
$16.16
Average daily volume
318K
Dividend rate
$0.48
Financial strength
Current ratio
2.912
Quick ratio
1.023
Long term debt to equity
280.002
Total debt to equity
289.49
Dividend payout ratio (TTM)
61.17%
Interest coverage (TTM)
3.57%
Profitability
EBITDA (TTM)
155.902
Gross margin (TTM)
32.27%
Net profit margin (TTM)
2.67%
Operating margin (TTM)
9.65%
Effective tax rate (TTM)
37.11%
Revenue per employee (TTM)
$610,000
Management effectiveness
Return on assets (TTM)
6.26%
Return on equity (TTM)
11.86%
Valuation
Price to earnings (TTM)
37.389
Price to revenue (TTM)
0.993
Price to book
4.45
Price to tangible book (TTM)
6.81
Price to free cash flow (TTM)
24.094
Free cash flow yield (TTM)
4.15%
Free cash flow per share (TTM)
121.11%
Dividend yield (TTM)
1.64%
Forward dividend yield
1.64%
Growth
Revenue change (TTM)
19.12%
Earnings per share change (TTM)
140.17%
3-year revenue growth (CAGR)
9.48%
10-year revenue growth (CAGR)
4.77%
3-year earnings per share growth (CAGR)
-18.64%
10-year earnings per share growth (CAGR)
-0.42%
10-year dividend per share growth (CAGR)
4.81%
What the Analysts think about PAHC
Analyst ratings (Buy, Hold, Sell) for Phibro Animal Health stock.
Bulls say / Bears say
Phibro Animal Health's acquisition of Zoetis's Medicated Feed Additive portfolio has significantly boosted net sales, with a 24% increase in Q2 2025, indicating strong market demand and successful integration. (panabee.com)
The company's 'Phibro Forward' initiative is expected to unlock additional revenue growth and cost savings, positioning Phibro for accelerated income growth beyond historical levels. (businesswire.com)
Phibro's Animal Health segment, particularly in vaccines and Medicated Feed Additives, has shown robust growth, with net sales increasing by 33% in Q2 2025, reflecting strong demand and effective product offerings. (panabee.com)
The company's net income for the fiscal year ended June 30, 2024, decreased by $30.2 million compared to the previous year, indicating profitability challenges. (businesswire.com)
Phibro's interest expense nearly doubled in Q2 2025 due to increased debt from financing the Zoetis acquisition, elevating financial risk. (panabee.com)
The company reported substantial foreign currency losses of $12 million in the first half of fiscal year 2025, indicating ongoing vulnerability to currency fluctuations. (panabee.com)
Data summarised monthly by Lightyear AI. Last updated on 10 Jul 2025.
PAHC Financial Performance
Revenues and expenses
PAHC Earnings Performance
Company profitability
PAHC News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Phibro Animal Health stock?
Phibro Animal Health (PAHC) has a market cap of $1.2B as of July 28, 2025.
What is the P/E ratio for Phibro Animal Health stock?
The price to earnings (P/E) ratio for Phibro Animal Health (PAHC) stock is 37.39 as of July 28, 2025.
Does Phibro Animal Health stock pay dividends?
Yes, the Phibro Animal Health (PAHC) stock pays dividends to shareholders. As of July 28, 2025, the dividend rate is $0.48 and the yield is 1.64%. Phibro Animal Health has a payout ratio of 61.17% on a trailing twelve-month basis.
When is the next Phibro Animal Health dividend payment date?
The next Phibro Animal Health (PAHC) dividend payment date is unconfirmed.
What is the beta indicator for Phibro Animal Health?
Phibro Animal Health (PAHC) has a beta rating of 0.62. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.